Reference: Taniokal, H., Taniokal, S., & Kaga, K. (2021). Why COVID-19 is not so spread in Africa: How does Ivermectin affect it? medRxiv. https://doi.org/10.1101/2021.03.26.21254377 Summary: This article explores the low incidence of COVID-19 in Africa, investigating the potential effects of ivermectin, a treatment for onchocerciasis, on morbidity and mortality rates. A statistical analysis was conducted […]
Reference: Yagisawa, M., Foster, P. J., Hanaki, H., & Ōmura, S. (2021). Global trends in clinical studies of ivermectin in COVID-19. The Japanese Journal of Antibiotics, 74(1), 44-73. https://doi.org/xxxxxx Summary: The article reviews the global response to the COVID-19 pandemic, particularly the role of ivermectin as a potential treatment. Initially regarded as ineffective, ivermectin gained
Reference: Yagisawa, M., Foster, P. J., Hanaki, H., & Ōmura, S. (2021). Global trends in clinical studies of ivermectin in COVID-19. The Japanese Journal of Antibiotics, 74(1), 44-75. Summary: The article reviews global clinical studies of ivermectin as a potential treatment for COVID-19. Initially, the outbreak was poorly communicated by the Chinese government, leading to
Reference: Bryant, A., Lawrie, T. A., Dowswell, T., Fordham, E., Hill, S., Mitchell, S., & Tham, T. (2021). The BIRD recommendation on the use of ivermectin for Covid-19: Proceedings and conclusions of the British Ivermectin Recommendation Development meeting held on the 20th February 2021 in Bath, United Kingdom. Evidence-Based Consultancy Medicine Ltd. Summary: The British
Reference: British Ivermectin Recommendation Development. (2021). The BIRD recommendation on the use of ivermectin for Covid-19: Executive summary. Proceedings and conclusions of the British Ivermectin Recommendation Development meeting. Summary: The British Ivermectin Recommendation Development (BIRD) meeting, held on 20th February 2021 in Bath, aimed to evaluate ivermectin’s efficacy in treating and preventing Covid-19, especially in
Reference: Kory, P., Meduri, G. U., Iglesias, J., Varon, J., & Marik, P. E. (2021). Review of the emerging evidence supporting the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. Front-Line COVID-19 Critical Care Alliance. Summary: This article by the Front Line COVID-19 Critical Care Alliance reviews the growing evidence supporting ivermectin’s effectiveness
Reference: FLCCC Alliance. (2021). I-MASK+ prophylaxis & early outpatient treatment protocol for COVID-19. Retrieved from www.flccc.net Summary: The FLCCC Alliance’s I-MASK+ protocol provides guidelines for the prophylaxis and early outpatient treatment of COVID-19. It recommends the use of Ivermectin, along with Vitamin D3, Vitamin C, Quercetin, Zinc, Melatonin, and Aspirin for high-risk individuals and post-exposure
Reference: McCullough, P. A., Alexander, P. E., Armstrong, R., Arvinte, C., Bain, A. F., Bartlett, R. P., … & Zelenko, V. (2020). Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). Reviews in Cardiovascular Medicine, 21(4), 517–530. https://doi.org/10.31083/j.rcm.2020.04.264 Summary: The article discusses a comprehensive approach to treat early ambulatory high-risk COVID-19
Reference: Kory, P., Meduri, G. U., Varon, J., Iglesias, J., & Marik, P. E. (2021). Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. American Journal of Therapeutics, 28(3), e299–e318. https://doi.org/10.1097/MJT.0000000000001163 Summary: This article reviews evidence supporting ivermectin as an effective treatment and prophylactic agent for COVID-19.
Reference: General patient consent form for pharmacies during 2021. Summary: General consent form drawn up for pharmacies dispensing Ivermecting to patients during 2021. DOWNLOAD